CTO

CTO

Haibao Zhu PH.D
 
Interesting in the flied of gene editing, cell therapy, and nano tissue engineering, Dr. Zhu has worked in Georgia Institute of Technology and Rice University for many years. Lots of research papers of Dr. Zhu have published in some top international academic journals, such as Nucleic Acids Research,Biomaterials,Molecular Therapy- Methods and Clinical Development.
Representative:
Cia-Hin Lau*, Haibao Zhu* (contribute equally), Johan Chin-Kang Tay, et al. Minimizing genetic recombination between repeat-variable di-residues (RVDs) for robust targeted genome engineering driven by the baculoviral-TALEN system. Molecular Therapy - Methods and Clinical Development (2014)1,14050; doi:10.1038/mtm.2014.50 
H. Zhu, et al, Baculoviral Transduction Facilitates TALEN-Mediated Targeted Transgene Integration and Cre/LoxP Cassette Exchange in Human-Induced Pluripotent Stem Cells, Nucleic Acids Research, (2013) doi:10.1093/nar/gkt721 
Zhu H, et al., Controlled growth and differentiation of MSCs on grooved films assembled from monodisperse biological nanofibers with genetically tunable surface chemistries. Biomaterials, 21, 2011(32): 4744-4752. 
H.B. Zhu, et al. Responses of free radicals to subcutaneous implantation of alginate–chitosan–alginate (ACA) microcapsules in mice. The International Journal of Artificial Organs, 32, 2009(4): 224-231. 
H.B. Zhu, et al. Osteogenic actions of the osteogenic growth peptide on bovine marrow mesenchymal stromal cells in culture. Veterinarni Medicina, 53, 2008 (9): 501–509. 
Zhaofang xi*, Haibao Zhu* (contribute equally), et al, IGF-1 protects myocardial cells from ROS stress induced apoptosis via up-regulating ARC. Journal of animal and veterinary advances. 11(11): 1901-1906, 2012.

@ 2017 Guangdong Trement Medical Science and Technology Co., Ltd